| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | +136.3% |
| SG&A Expense | $1.0M | +426.1% |
| Operating Income | -$5.9M | -130.7% |
| Net Income | -$6.6M | -117.7% |
| EPS (Basic) | -$3.53 | -1117.2% |
| EPS (Diluted) | -$3.53 | -1117.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -69.4% |
| Short-term Investments | $2.9M | — |
| Current Assets | $5.6M | -34.8% |
| Total Assets | $6.0M | -31.2% |
| Current Liabilities | $1.0M | +6.8% |
| Total Liabilities | $1.9M | +94.3% |
| Stockholders' Equity | $4.1M | -47.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | -105.9% |
| Capital Expenditures | $19K | — |
| Investing Cash Flow | -$2.8M | — |
| Financing Cash Flow | $2.6M | -75.8% |
| Free Cash Flow | -$5.6M | — |